Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2025-12-24 @ 4:18 PM
NCT ID:
NCT02796066
Eligibility Criteria:
Inclusion Criteria:
* Healthy males or females, 16 to 55 years of age
* Must be diagnosed as having moderate or severe acne vulgaris
* ≥ 20 inflammatory lesions on the face
* ≥ 20 non-inflammatory lesions on the face
* ≤ 3 nodule/cyst acne lesions
* Medically healthy
* Females must be of non-childbearing potential
Exclusion Criteria:
* Systemic therapy with retinoids within six (6) months prior to study start
* Topical use of prescription retinoids within four (4) weeks prior to study start
* Oral antibiotics within four (4) weeks prior to study start
* Topical dapsone, sulfacetamide, benzoyl peroxide, α-hydroxy/glycolic acid and retinol/retinaldehyde-containing products, and topical antibiotics, anti-inflammatory medications and corticosteroids on the face within two (2) weeks prior to study start
* Facial procedures, including lasers, peels, and dermabrasion, within two (2) months prior to study start
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
55 Years
Study:
NCT02796066
Study Brief:
Protocol Section:
NCT02796066